FDA approves Tecentriq after surgery for a type of stage III colon cancer
Adding the immunotherapy to chemo cut the risk of the cancer returning or death by half in a 712-patient trial. It is for tumors with a specific genetic marker.
Roche
The Healthcare News Network
Your daily guide to Medicare, insurance, medicines and staying well
New FDA approvals, drug prices, recalls and what changes in your medicine cabinet.

Adding the immunotherapy to chemo cut the risk of the cancer returning or death by half in a 712-patient trial. It is for tumors with a specific genetic marker.
Roche
Four 28-ounce flavors may contain Yellow 5 or 6 not named on the label. The FDA rates the risk as low.
The Healthy

Medicare now negotiates prices on popular drugs like Eliquis, Jardiance and Ozempic. See the full lists for 2026, 2027 and 2028 and what it means for you.
Updated October 11, 2026